Category: misconduct investigations

Singapore university revokes second researcher’s PhD in misconduct fallout

Last year, the fallout from a misconduct investigation at Nanyang Technological University (NTU) in Singapore resulted in the university revoking the PhD of a Harvard research fellow, and a senior researcher losing his job. In July 2016, NTU told us another researcher who could not be named at the time had also come forward and confessed to making up data.

Now, Retraction Watch has learned that Sabeera Bonala — the researcher who couldn’t be named due to ongoing disciplinary procedures last year — has also had her doctorate degree revoked by the NTU. Continue reading Singapore university revokes second researcher’s PhD in misconduct fallout

Swedish review board finds misconduct by Macchiarini, calls for six retractions

Paolo Macchiarini

An ethical review board in Sweden is asking journals to retract six papers co-authored by former star surgeon Paolo Macchiarini, after concluding that he and his co-authors committed misconduct.

One of the papers is the seminal 2011 article in The Lancet, which described the first case of a transplant using an artificial trachea seeded with the patient’s own stem cells, and now bears an expression of concern from The Lancet editors. Over time, multiple authors have asked to be removed from the paper.

The Expert Group on Scientific Misconduct at the Central Ethical Review Board has determined that concerns over that paper — and five others co-authored by Macchiarini, once based at the Karolinska Institutet (KI) — were justified. In a press release, it says:

Continue reading Swedish review board finds misconduct by Macchiarini, calls for six retractions

Florida researcher “cherry picked” data, university investigation finds

Credit: University of Florida

A journal has retracted a 2014 paper after a university investigation found that the first author only reported certain data points that supported the paper’s conclusion.

Based on a whistleblower’s tip, the University of Florida investigated work by Huabei Jiang, a professor of biomedical engineering, and Lei Yao, a former postdoc and scientist in Jiang’s lab, for research misconduct. According to documents obtained by Retraction Watch through a  public records request, in 2015 Yao confessed to selectively choosing data in an email to the whistleblower. Continue reading Florida researcher “cherry picked” data, university investigation finds

Caught Our Notice: Another retraction for researcher paid $100k to leave uni

Via Wikimedia

When Retraction Watch began in 2010, our co-founders Ivan Oransky and Adam Marcus quickly realized they couldn’t keep up with the hundreds of retractions that appeared each year.  And the problem has only gotten worse — although we’ve added staff, the number of retractions issued each year has increased dramatically. According to our growing database, just shy of 1,000 retractions were issued last year (and that doesn’t include expressions of concern and errata). So to get new notices in front of readers more quickly, we’ve started a new feature called “Caught our Notice,” where we highlight a recent notice that stood out from the others. If you have any information about what happened, feel free to contact us at [email protected].

Title:  Diabetes and Overexpression of proNGF Cause Retinal Neurodegeneration via Activation of RhoA Pathway  and  Diabetes-Induced Superoxide Anion and Breakdown of the Blood-Retinal Barrier: Role of the VEGF/uPAR Pathway 

What caught our attention:

Continue reading Caught Our Notice: Another retraction for researcher paid $100k to leave uni

Researcher apologizes for ignoring early warnings about earthquake data

In 2016, three researchers published data they had collected on a series of devastating earthquakes that hit Japan earlier that year.

But, in late September 2017, one of the authors—Hiroyuki Goto—revealed that the Kumamoto Earthquake data contained “wide reaching errors”—and an outside expert had warned him the data might be problematic nine months earlier.  

Goto, an associate professor in the Disaster Prevention Research Institute at Kyoto University, issued two statements in which he acknowledged the errors, but did not indicate how they occurred. According to The Japan Times, Japan’s Ministry of Education, Culture, Sports, Science and Technology is investigating whether the data “was falsified or fabricated due to inconsistencies with other readings taken nearby.” A report in another Japanese paper, The Mainichi, notes that Osaka University—where one of the authors, Yoshiya Hata, works—is looking into the matter as well.

Continue reading Researcher apologizes for ignoring early warnings about earthquake data

Swedish prosecutor won’t pursue criminal case against Macchiarini

Paolo Macchiarini

A Swedish prosecutor has announced she won’t continue investigating a former star surgeon who has since fallen from grace.

Paolo Macchiarini made a name for himself by transplanting synthetic tracheas. After multiple patients died, however, allegations against the researcher have continued to swirl. He was dismissed from the Karolinska Institutet last year, after it reopened its misconduct investigation. The Swedish prosecutor was investigating Macchiarini’s role in the deaths of three out of four patients he operated on five times between 2011-2013.

Although the prosecution concluded that most of the operations proceeded “negligently,” it could not conclude Macchiarini was criminally responsible.

According to the public prosecutor Jennie Nordin:

Continue reading Swedish prosecutor won’t pursue criminal case against Macchiarini

Early data on potential anti-cancer compound now in human trials was falsified, company admits

A pharmaceutical company has admitted that one of its former researchers falsified early data on a compound that’s designed to fight cancer, now in human trials.

The data, published as an abstract in August 2015 in the journal Cancer Research, reported a therapeutic benefit of acalabrutinib in a mouse model of pancreatic cancer. The compound, developed by the company Acerta Pharma, has also been the subject of additional trials published in the New England Journal of Medicine and Blood in 2015. The 2015 NEJM study, which had several authors in common with the Cancer Research abstract, showed the agent had “promising safety and efficacy profiles in patients” with relapsed chronic lymphocytic leukemia.

But an investigation into the data underlying the 2015 abstract shows some were falsified, prompting the journal to retract the abstract.

Ed Tucker, senior vice president of Medical Safety, Quality and Compliance at Acerta Pharma, told us that in August 2016 the company identified an issue with the data in the Cancer Research abstract and started an investigation:

Continue reading Early data on potential anti-cancer compound now in human trials was falsified, company admits

Journal adds concern notice to paper by psychologist Jens Förster

A social psychology journal has added an expression of concern to a paper by prominent social psychologist Jens Förster, whose work has been subject to much scrutiny.

This is the latest in a long-running saga involving Förster. The 2012 paper in the Journal of Experimental Social Psychology had been flagged by a 2015 report describing an investigation into Förster’s work, which had concluded the paper likely contained unreliable data. Several other papers that received similar designations in that report have either been retracted or received expressions of concern (EoC).

The (paywalled) notice provides a lengthy explanation for why the journal chose to add an EoC, rather than retract the paper, as the University of Amsterdam had recommended. Here is an excerpt:

Continue reading Journal adds concern notice to paper by psychologist Jens Förster

“No wrongdoing had occurred,” says Karolinska, following investigation of cancer research

A journal has removed an expression of concern for a 2011 paper after Karolinska Institutet (KI) “concluded no wrongdoing had occurred.” 

In June, Journal of Cell Science (JCS) issued the expression of concern, after a reader contacted the editors with questions about the data in one of the figures. JCS investigated but could not resolve the issue, and in March 2017 turned the case over to KI where the authors are based.

The 2011 paper had already received a correction in 2016, citing inadvertent figure duplication.

In late August, KI concluded its investigation into the 2011 paper by last author Boris Zhivotovsky; JCS has now updated the expression of concern with a publisher’s note: Continue reading “No wrongdoing had occurred,” says Karolinska, following investigation of cancer research

Author blamed for misconduct in Cell paper declines to sign retraction notice  

Researchers have retracted a 2015 paper in Cell after an investigation revealed the first author committed misconduct.

According to the retraction notice, which first author Ozgur Tataroglu declined to sign, the researchers realized there was an issue with the 2015 paper when they were unable to replicate the findings. Corresponding author Patrick Emery and his team at the University of Massachusetts Medical School in Worcester reviewed the data and found “clear evidence” that Tataroglu  — who had been a postdoc in Emery’s lab — “had repeatedly misrepresented and altered primary data,” the notice states.

UMass subsequently conducted an investigation in which it “concluded that the first author committed scientific misconduct.”  

Here’s the retraction notice for “Calcium and SOL Protease Mediate Temperature Resetting of Circadian Clocks:” Continue reading Author blamed for misconduct in Cell paper declines to sign retraction notice